Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-18 Sale |
2024-03-19 6:45 pm |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
9,211 | $5.0425 | $46,446 | 167,550 (Direct) |
View |
| 2023-06-09 Sale |
2023-06-13 8:09 pm |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
5,000 | $30.82 | $154,096 | 147,347 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-16 8:29 pm |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
21,015 | $34.55 | $726,003 | 152,347 (Direct) |
View |
| 2023-03-09 Sale |
2023-03-09 9:45 pm |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
21,508 | $31.59 | $679,358 | 123,934 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-15 Tax Withholding |
2024-03-19 6:45 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
2,967 | $5.305 | 167,550 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-04 5:34 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
22,110 | $0 | 179,728 (Direct) |
View |
| 2023-12-31 Option Award |
2024-01-03 4:50 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
264 | $7.47 | 157,618 (Direct) |
View |
| 2023-12-15 Tax Withholding |
2023-12-18 4:32 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
4,712 | $8.08 | 157,354 (Direct) |
View |
| 2023-08-11 Option Award |
2023-08-15 4:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
22,620 | $0 | 162,066 (Direct) |
View |
| 2023-08-11 Tax Withholding |
2023-08-15 4:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
8,901 | $18.91 | 162,066 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:11 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
1,000 | $15.61 | 148,347 (Direct) |
View |
| 2022-02-02 Option Award |
2023-05-16 8:29 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
52,395 | $0 | 152,347 (Direct) |
View |
| 2023-03-15 Tax Withholding |
2023-03-17 3:21 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
2,967 | $30.65 | 120,967 (Direct) |
View |
| 2022-09-22 Option Award |
2023-03-09 9:45 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
52,396 | $0 | 123,934 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-16 8:29 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
2,766 | $33.21 | 93,046 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 9:37 pm |
N/A 2033-01-30 |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
43,255 | $0 | 43,255 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-03 4:28 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
605 | $12.18 | 95,812 (Direct) |
View |
| 2022-12-15 Tax Withholding |
2022-12-16 4:11 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
2,916 | $21.5 | 95,207 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 6:15 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
1,000 | $11.75 | 98,123 (Direct) |
View |
| 2022-03-15 Tax Withholding |
2022-03-17 5:43 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
1,835 | $15.79 | 97,123 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-17 8:54 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
2,429 | $13.35 | 98,958 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 8:38 pm |
N/A 2032-02-01 |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
57,016 | $0 | 57,016 (Direct) |
View |
| 2021-12-15 Tax Withholding |
2021-12-17 5:29 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
513 | $15.92 | 101,387 (Direct) |
View |
| 2021-11-09 Option Award |
2021-11-10 8:32 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S President |
35,920 | $0 | 101,900 (Direct) |
View |
| 2021-06-30 Other |
2021-07-02 7:56 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S Chief Commercial Officer |
882 | $24.09 | 66,862 (Direct) |
View |
| 2021-04-15 Tax Withholding |
2021-04-16 8:17 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S Chief Commercial Officer |
411 | $28.16 | 65,098 (Direct) |
View |
| 2021-02-15 Tax Withholding |
2021-02-19 8:13 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S Chief Commercial Officer |
2,410 | $28.97 | 65,509 (Direct) |
View |
| 2021-02-02 Option Award |
2021-02-04 9:16 pm |
N/A 2031-02-01 |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S Chief Commercial Officer |
63,545 | $0 | 108,844 (Direct) |
View |
| 2020-12-31 Other |
2021-01-04 7:59 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S Chief Commercial Officer |
348 | $21.36 | 45,647 (Direct) |
View |
| 2020-12-15 Tax Withholding |
2020-12-22 8:37 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S Chief Commercial Officer |
562 | $26.75 | 44,951 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-02 8:34 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S Chief Commercial Officer |
6,051 | $25.14 | 45,513 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 8:34 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S Chief Commercial Officer |
17,500 | $0 | 45,513 (Direct) |
View |
| 2020-06-30 Other |
2020-07-02 8:20 pm |
N/A N/A |
Revance Therapeutics Inc. | RVNC | Sjuts Dustin S Chief Commercial Officer |
1,000 | $13.8 | 35,064 (Direct) |
View |